On March 26, the FDA approved a drug from Merck to treat adults with pulmonary arterial hypertension — a rare, progressive lung condition. 

About 30 pharmacists and pharmacy technicians at a Las Vegas CVS Omnicare filed to unionize March 25, making them the first in their industry to seek unionization. 

More than a year after the FDA yanked away authorization from Evusheld, a monoclonal antibody treatment for COVID-19, the agency granted emergency use authorization to a new COVID-19 preventive drug March 22. 

Wegovy and Ozempic maker Novo Nordisk has agreed to buy Cardior Pharmaceuticals for $1.11 billion. The acquisition is part of Novo Nordisk's larger strategy to build a portfolio of therapies in cardiovascular disease. 

A former CVS location is now occupied by a United Health Services pharmacy. 

On March 22, the FDA granted emergency use authorization to Pemgarda, a COVID-19 preventive medication, for patients 12 and older. 

The FDA has approved Duvyzat as the first nonsteroidal drug for patients with all genetic variants of Duchenne muscular dystrophy, the agency said March 21.

Researchers and pharmacists at West Virginia University are developing AI technology to streamline medication reconciliation in hospitals, or the standard of reviewing a patient's drug regimen before discharges. 

Mark Cuban Cost Plus Drug Co. expanded its pharmacy network March 20 with a deal with grocery chain Albertsons, growing its drug discount offering by another thousand-plus locations. 

The most expensive drug in the U.S. is now Lenmeldy, a $4.25 million gene therapy the FDA approved March 18 for children with a rare genetic disease. 

More than half of pharmaceuticals in the United States have a dependency on manufacturers not compliant to the Trade Agreements Act, which the Department of Defense defines as high- and very high-risk medications. 

In 2023, 63% of abortions were performed with abortion pills — an increase from 2020, when the figure was 53%, according to the Guttmacher Institute. 

Pharmaceutical company AstraZeneca plans to acquire biotech company Fusion Pharmaceuticals for up to $2.4 billion, Investopedia reported March 19. 

Unreasonable workload expectations and staffing and scheduling issues ranked highest among negative experiences reported by pharmacy workers in 2023, according to a workplace and well-being report published March 18. 

On March 18, the FDA approved the first gene therapy for children with metachromatic leukodystrophy, a debilitating, rare genetic disease. 

Livonia, Mich.-based Trinity Health is temporarily shuttering its pharmacy on Eastern Michigan University's campus. 

After the FDA questioned the safety of two CAR-T therapies, members of the agency's Oncologic Drugs Advisory Committee voted unanimously to recommend Carvykti, made by Janssen Biotech, and voted 8-3 in favor for Abecma, from Bristol-Myers Squibb K.K.

Detroit-based Henry Ford Health said its centralized pharmacy services center, which opened in September, is designed to save the system $30 million over five years. 

On March 14, the FDA approved the nation's first medication to treat noncirrhotic non-alcoholic steatohepatitis with fibrosis, or fatty liver scarring. 

After months of 10 p.m. Saturday emails about utilization trends and "pain points" at Community Health Systems, Mark Cuban Cost Plus Drug Co. secured its first hospital system partnership. Compared to other drugmakers, CHS leaders called the relationship unique.